尼罗利多尔对双边尿道阻塞后功能障碍的作用
Harun R Toumi1, Sundus M Sallabi1, Loay Lubbad1
1Department of Surgery, College of Medicine & Health Sciences, United Arab Emirates University, Al Ain P.O. Box 17666, United Arab Emirates.
Biomedicines
|October 26, 2024
概括
尼罗利多尔是一种天然化合物,显示出对双边尿路阻塞 (BUO) 引起的损伤的保护作用. 在BUO模型中,这种天然疗法有助于维护功能,减少炎症和氧化应激.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 自然产品研究 自然产品研究
背景情况:
- 阻塞性泌尿病是造成功能障碍的重要原因之一.
- 由于安全性和可用性,天然产品因其治疗潜力而受到越来越多的关注.
- 研究像尼罗利多尔这样的天然化合物提供了替代治疗策略.
研究的目的:
- 在双边尿路阻塞 (BUO) 的大鼠模型中评估尼罗利多尔的脏保护作用.
- 评估尼罗利多尔对功能,炎症,亡和氧化应激标志物的影响.
主要方法:
- 威斯塔大鼠接受了可逆的24小时双侧尿管阻塞 (BUO).
- 尼罗利多尔 (200 mg/kg) 或载体是每天口服的,从BUO逆转之前开始,持续到BUO逆转后.
- 分析了功能,生化标志物和组织学变化.
主要成果:
- 尼罗利多尔治疗显著改善了功能参数,包括血清肌素和尿素水平.
- 它减弱了BUO诱导的尿白蛋白-肌素比率和损伤标志物的增加.
- 尼罗利多尔降低了炎症,亡和氧化应激的标志物,并减轻了组织学损伤.
结论:
- 尼罗利多尔对双边泌尿管阻塞诱导的损伤表现出强大的保护作用.
- 它的益处归因于其抗炎,抗纤维,抗亡和抗氧化性质.
- 这些发现表明尼罗利多尔在阻塞性尿路病的潜在治疗应用.
相关概念视频
Factors Affecting Renal Clearance: Renal Impairment
58
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
58
Heart Failure Drugs: Diuretics
346
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
346
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
394
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
394
Renal Failure: Dose Adjustments
67
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
67
Antihypertensive Drugs: Action of Diuretics
624
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
624
Antihypertensive Drugs: Direct Renin Inhibitors
499
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
499


